PREEMPTIVE RITUXIMAB TREATMENT MAY REDUCE THE INCIDENCE OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) IN PATIENTS WITH EBV REACTIVATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

被引：1
|
作者：
Kindwall-Keller, T. L. [1 ]
Cooper, B. W. [1 ]
Laughlin, M. J. [1 ]
Gerson, S. L. [1 ]
Barr, P. [1 ]
Erinc, S. [1 ]
Creger, R. J. [1 ]
Lazarus, H. M. [1 ]
机构：
[1] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.282
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
250
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [31] Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Hebert, Courtney
    Watts, Nicole
    Isaac, Shiney
    Kukkamalla, Rivvi
    Jamy, Omer
    Saad, Ayman
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S276 - S277
  • [32] Prolonged Hypogammaglobulinemia After Rituximab Therapy for Post-Transplant EBV-Lymphoproliferative Disorder Following Hematopoietic Stem Cell Transplantation in Pediatric Patients
    Pluchart, Claire
    Lescoeur, Brigitte
    Guerin, Valerie
    Duquesne, Frederique
    Seror, Elisa
    Pedron, Beatrice
    Yakouben, Karima
    Ouachee, Marie
    Baruchel, Andre
    Sterkers, Ghislaine
    Halle, Jean-Hugues
    BLOOD, 2012, 120 (21)
  • [33] Transfer of EBV-specific T-cells: a treatment option for patients with EBV-associated post-transplant lymphoproliferative disease after allogeneic stem cell transplantation
    Tischer, J.
    Moosmann, A.
    Bigalke, I.
    Prevalsek, D.
    Fritsch, S.
    Mumm, F.
    Rank, A.
    Heilmeier, B.
    Bergmann, M.
    Hill, W.
    Hausmann, A.
    Ledderose, G.
    Kolb, H. J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S209 - S209
  • [34] Rituxan administration for the treatment of posttransplant lymphoproliferative disorders (PTLD) may reduce or eliminate the need for post-transplant immunosuppression.
    Venugopal, P
    Orlowski, JM
    Leslie, WT
    Berkahn, L
    Grillo-Lopez, A
    Gregory, SA
    BLOOD, 1999, 94 (10) : 269B - 269B
  • [35] Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation
    Romero, Samuel
    Montoro, Juan
    Guinot, Marta
    Almenar, Luis
    Andreu, Rafael
    Balaguer, Aitana
    Beneyto, Isabel
    Espi, Jordi
    Gomez-Codina, Jose
    Iacoboni, Gloria
    Jarque, Isidro
    Lopez-Andujar, Rafael
    Mayordomo-Aranda, Empar
    Montalar, Joaquin
    Pastor, Amparo
    Pastor, Miguel
    Pinana, Jose L.
    Rojas-Ferrer, Nohelia
    Sanchez-Lazaro, Ignacio
    Sandoval, Jesus
    Sanz, Guillermo
    Sanz, Miguel A.
    Sole, Amparo
    Sanz, Jaime
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 142 - 150
  • [36] Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation
    Ru, Yuhua
    Chen, Jia
    Wu, Depei
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 283 - 290
  • [37] Who is the patient at risk for EBV reactivation and disease: expert opinion focused on post-transplant lymphoproliferative disorders following hematopoietic stem cell transplantation
    Marjanska, Agata
    Styczynski, Jan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (06) : 539 - 552
  • [38] Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission
    Knoop, C
    Kentos, A
    Remmelink, M
    Garbar, C
    Goldman, S
    Feremans, W
    Estenne, M
    CLINICAL TRANSPLANTATION, 2006, 20 (02) : 179 - 187
  • [39] EBV-reactivation, -disease and EBV-induced post-transplant lymphoproliferative disease after haploidentical stem cell transplantation:: a single-centre experience of 57 patients
    Tischer, J
    Rieger, C
    Ledderose, G
    Hill, W
    Weisser, M
    Schmid, C
    Jäger, G
    BONE MARROW TRANSPLANTATION, 2005, 35 : S173 - S173
  • [40] Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
    Zhu, Cheng-ying
    Zhao, Sha-sha
    Wang, Xiao-kai
    Wang, Li
    Wang, Fei-yan
    Fang, Shu
    Liu, Zhan-xiang
    Guan, Li-xun
    Liu, Yu-chen
    Ding, Yi
    Dou, Li-ping
    Wang, Li-li
    Gao, Chun-ji
    ANNALS OF TRANSPLANTATION, 2019, 24 : 175 - 184
12345